China's relentless focus on GDP growth has created unchecked industrial pollution, contaminating the nation's food supply. The story of one so-called 'cancer village' in Yunnan province where residents are dying.

Many believe genetics are the next big thing in medicine, but one question for this new era of personalized medicine is cost.

The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.

Why one woman refused to let cancer alter her retirement planning.

If the folks behind the Great American Smokeout have their way, the latest frontier in the “no smoking” crusade could be apartment buildings.

This week, India's Supreme Court hears arguments in a case that will affect how many poor people can afford cancer drugs. Novartis is defending a patent on its cancer medication, Gleevec.

The residents of Roxana, Ill. debate if the oil refineries in and around their town represent jobs and money, cancer or something else.

The agency that monitors drugs in sports is bringing formal doping charges against cyclist Lance Armstrong. Armstrong has denied the allegations, but how will the charges affect his charitable organization Livestrong?

A new study shows that cancer patients prefer riskier approaches with very low odds of success , over more successful ones that wouldn't extend their lives as long.

President Richard Nixon used the phrase "war on cancer" in signing the National Cancer Act of 1971. Forty years later, scientists say our understanding of cancer has outgrown a military analogy.